|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 16 June 2004
doi: 10.1242/dev.01179
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA
Author for correspondence (e-mail:
pfaff{at}salk.edu)
Accepted 22 March 2004
The underlying transcriptional mechanisms that establish the proper spatial and temporal pattern of gene expression required for specifying neuronal fate are poorly defined. We have characterized how the Hb9 gene is expressed in developing motoneurons in order to understand how transcription is directed to specific cells within the developing CNS. We found that non-specific general-activator proteins such as E2F and Sp1 are capable of driving widespread low level transcription of Hb9 in many cell types throughout the neural tube; however, their activity is modulated by specific repressor and activator complexes. The general-activators of Hb9 are suppressed from triggering inappropriate transcription by repressor proteins Irx3 and Nkx2.2. High level motoneuron expression is achieved by assembling an enhancesome on a compact evolutionarily-conserved segment of Hb9 located from –7096 to –6896. The ensemble of LIM-HD and bHLH proteins that interact with this enhancer change as motoneuron development progresses, facilitating both the activation and maintenance of Hb9 expression in developing and mature motoneurons. These findings provide direct support for the derepression model of gene regulation and cell fate specification in the neural tube, as well as establishing a role for enhancers in targeting gene expression to a single neuronal subtype in the spinal cord.
Key words: Motoneuron, Development, Hb9, Enhancer, Gene regulation, Derepression
This article has been cited by other articles:
|
|
 |
|
  B. W. Gallarda, D. Bonanomi, D. Muller, A. Brown, W. A. Alaynick, S. E. Andrews, G. Lemke, S. L. Pfaff, and T. Marquardt Segregation of Axial Motor and Sensory Pathways via Heterotypic Trans-Axonal Signaling Science, April 11, 2008; 320(5873): 233 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Guillemot Spatial and temporal specification of neural fates by transcription factor codes Development, November 1, 2007; 134(21): 3771 - 3780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Etchberger, A. Lorch, M. C. Sleumer, R. Zapf, S. J. Jones, M. A. Marra, R. A. Holt, D. G. Moerman, and O. Hobert The molecular signature and cis-regulatory architecture of a C. elegans gustatory neuron Genes & Dev., July 1, 2007; 21(13): 1653 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Von Stetina, R. M. Fox, K. L. Watkins, T. A. Starich, J. E. Shaw, and D. M. Miller III UNC-4 represses CEH-12/HB9 to specify synaptic inputs to VA motor neurons in C. elegans Genes & Dev., February 1, 2007; 21(3): 332 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Mizuhara, T. Nakatani, Y. Minaki, Y. Sakamoto, and Y. Ono Corl1, a Novel Neuronal Lineage-specific Transcriptional Corepressor for the Homeodomain Transcription Factor Lbx1 J. Biol. Chem., February 4, 2005; 280(5): 3645 - 3655. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-K. Lee, B. Lee, E. C. Ruiz, and S. L. Pfaff Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells Genes & Dev., January 15, 2005; 19(2): 282 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schwander, R. Shirasaki, S. L. Pfaff, and U. Muller {beta}1 Integrins in Muscle, But Not in Motor Neurons, Are Required for Skeletal Muscle Innervation J. Neurosci., September 15, 2004; 24(37): 8181 - 8191. [Abstract] [Full Text] [PDF]
|
|
